Clinical Trials
52 trialsMetformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer
Thomas Jefferson University
Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
Medical University of South Carolina
Metformin to Mitigate Sequelae of Radioactive Iodine Treatment for Thyroid Cancers
Thomas Jefferson University
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
Columbia University
Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions
Thomas Jefferson University
Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy
M.D. Anderson Cancer Center
OMgObPCOS
Coordinación de Investigación en Salud, Mexico
Temsirolimus in Combination With Metformin in Patients With Advanced Cancers
M.D. Anderson Cancer Center
NivoMet
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
ASAMET
Ente Ospedaliero Ospedali Galliera
PRIME
Canadian Urologic Oncology Group
Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant
Semnan University of Medical Sciences
Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By Surgery
Vanderbilt-Ingram Cancer Center
PREMIUM
AHS Cancer Control Alberta
Metformin Pharmacology in Human Cancers: A Proof of Principle Study
Dartmouth-Hitchcock Medical Center
Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone
Swiss Cancer Institute
PRIMA
Rutgers, The State University of New Jersey
DLBCL
Rush University Medical Center
SAKK 08/15 - PROMET - Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy
Swiss Cancer Institute
NeoMET
Shanghai Jiao Tong University School of Medicine
PULSE
Pennington Biomedical Research Center
Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
National Institutes of Health Clinical Center (CC)
RADFORMIN
University Hospital, Antwerp
INSIDE
Sahlgrenska University Hospital
Exemestane-RAD001-Metformin
M.D. Anderson Cancer Center
ALMERA
Ontario Clinical Oncology Group (OCOG)
Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer
Mayo Clinic
Metformin in Non Small Cell Lung Cancer (NSCLC)
M.D. Anderson Cancer Center
Comparison of Melatonin or Metformin and Dacarbazine Combination Versus Dacarbazine Alone in Disseminated Melanoma
N.N. Petrov National Medical Research Center of Oncology
Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer
Avera McKennan Hospital & University Health Center
Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML
Northwestern University
G-LUCAS
Austrian Breast & Colorectal Cancer Study Group
Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer
Gachon University Gil Medical Center
METRO
Beth Israel Medical Center
NEOMETRE
University of Campinas, Brazil
DLBCL
Rush University Medical Center
Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer
M.D. Anderson Cancer Center
Metformin in Castration-Resistant Prostate Cancer
Massachusetts General Hospital
Pilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interactions, on Tumor Metabolism and Anoikis
West Virginia University
METFOVIR
Assistance Publique - Hôpitaux de Paris
Metformin in Stage IV Lung Adenocarcinoma
National Cheng-Kung University Hospital
Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth
University of Arkansas
An Open-Labeled Pilot Study of Biomarker Response Following Short-Term Exposure to Metformin
M.D. Anderson Cancer Center
PACT-17
IRCCS San Raffaele
Impact of Pretreatment With Metformin on Colorectal Cancer Stem Cells (CCSC) and Related Pharmacodynamic Markers
Tufts Medical Center
Metformin and Transient Hyperglycemia
Children's Hospital Los Angeles
Combination Metformin and Oral Contraception for Polycystic Ovary Syndrome (PCOS)
Virginia Commonwealth University
Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast Cancer
Fondazione Michelangelo
ANIMATE
University Health Network, Toronto